Pharmafile.com’s weekly COVID-19 news round-up
May 26, 2021Research and Development
The past week has seen lots of positive COVID-19 news; a French study has found that dogs can detect COVID-19 …
Australian study sees 70% HPV reduction in gay and bisexual men
May 26, 2021Research and Development Australia, HPV, Vaccine
A school-based human papillomavirus (HPV) vaccination study programme, led by Monash University and Alfred Health, found a 70% reduction in …
Moderna vaccine shows 100% efficacy in teens
May 26, 2021Research and Development
Moderna’s TeenCOVE study, involving 3,700 adolescents aged 12 to less than 18 years old, observed no cases of COVID-19 after …
Ori Biotech and Vineti to collaborate on CGT manufacturing
May 26, 2021Research and Development AI, CGTs
Ori Biotech and Vineti have announced a strategic partnership to produce pre-integrated solutions to fast-track and streamline the manufacture and …
NICE recommends inducing woman in labour earlier than previously advised
May 25, 2021Manufacturing and Production
In new draft guidance published today NICE has recommended that inducing women in labour earlier than previously advised will make …
Takeda: Dengue vaccine successful in long-term trials & set for global distribution
May 25, 2021Manufacturing and Production EMA, Vaccine, dengue
Japanese pharma company Takeda has announced long-term safety and efficacy results for its dengue vaccine candidate, TAK-003, and has successfully …
Man’s eyesight partially restored with optogenetic therapy
May 25, 2021Manufacturing and Production
A man in France has had his eyesight restored after 20 years of complete blindness, in the first reported case …
New research begins on producing HIV treatments in plants
May 25, 2021Manufacturing and Production
St George’s, University of London has announced a partnership with Leaf Expression Systems to produce HIV treatments in plants. The …
CMA to review AstraZeneca’s $39 billion buyout of Alexion
May 25, 2021Manufacturing and Production
The UK’s Competition and Markets Authority (CMA) is to review AstraZeneca’s $39 billion buyout of US-based Alexion Pharmaceuticals. The COVID-19 …
CDC investigating post-vaccine inflammation reports in the US
May 24, 2021Sales and Marketing
The US Centers for Disease Control (CDC) is looking in to a small number of reports that some young vaccine …
C. difficile infection Phase III trial meets primary endpoint
May 24, 2021Sales and Marketing
Ferring Pharmaceuticals and Rebiotix have presented Phase III results demonstrating superior efficacy of investigational RBX2660 in reducing recurrence of Clostridioides …
FDA grants accelerated approval for Janssen’s lung cancer drug
May 24, 2021Sales and Marketing
The FDA have granted accelerated approval of Rybrevant (amivantamab-vmjw) for the treatment of patients with metastatic non-small cell lung cancer …
Vaccines highly effective against Indian variant, study shows
May 24, 2021Sales and Marketing
A new Public Health England (PHE) study shows that two doses of either the Pfizer-BioNTech or the Oxford-AstraZeneca vaccine are …
BMS follow-up data sees long-term survival for melanoma patients
May 24, 2021Sales and Marketing BMS, skin cancer
Bristol Myers Squibb (BMS) has announced follow-up data from their Phase III CheckMate-067 clinical trial, which demonstrated that 49% of …
NICE rejects Janssen’s prostate cancer drug Erleada
May 21, 2021Medical Communications
NICE has published has published draft guidance rejecting Janssen’s Erleada (apalutamide) with androgen deprivation therapy (ADT) for treating prostate cancer. …
Australian PM calls for domestic mRNA vaccine production
May 21, 2021Medical Communications Australia, Moderna, Vaccine, mrna
Australian Prime Minister, Scott Morrison, has invited proposals from pharmaceutical firms to establish domestic manufacturing of mRNA vaccines, to strengthen …
Japan approves Moderna & AstraZeneca COVID-19 vaccines
May 21, 2021Medical Communications COVID-19, Japan, Vaccine
A Japanese government panel has approved Moderna and AstraZeneca’s COVID-19 vaccines for use in adults, bringing the total number of …
Dogs can detect COVID-19 with 97% accuracy, study finds
May 21, 2021Medical Communications
A French trial has found has found that dogs are able to detect COVID-19 with 97% accuracy in humans, which …
Pharmafile.com’s top 10 news stories of the week
May 21, 2021Medical Communications
Among our ten most-read stories this week: Delayed Pfizer vaccine dose gives 3.5 times more immunity, study shows, while a …
EU signs contract for 1.8bn more Pfizer vaccines
May 20, 2021The European Commission has signed a deal with Pfizer-BioNTech to purchase an additional 1.8 billion doses of its COVID-19 vaccine …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
